The world's first inhalable COVID-19 vaccine was unveiled. What was the effect?

The effect of this inhaled COVID-19 vaccine is still acceptable. Its formula is exactly the same as that of the original COVID-19 vaccine, and there is no corresponding change, but the way of administration is different, so we can clearly know that the efficacy of this vaccine is the same as that of our vaccination, but this vaccine is to help some friends who don't like injections.

According to relevant data, this global inhaled COVID-19 vaccine was developed by the team of Academician Chen Wei of the Military Medical Research Institute in cooperation with Kangxinuo Biological Co., Ltd. At present, this vaccine has achieved phased results in the second phase of clinical trials, and it has been urgently promoted and opened to the whole society. The effect of this vaccine is very good. In addition to the original formula, it can also strongly induce humoral immunity and cellular immunity in vivo by atomizing inoculation, and it is well tolerated without causing any serious adverse reactions related to the vaccine. This is why the society is very concerned about this vaccine now, hoping that more related problems can be solved through this vaccine.

Besides strongly stimulating humoral immunity and cellular immunity in vivo, this vaccine is safer than traditional vaccine injection. Only the dosage of 1/5 is used for intramuscular injection, and there is no local adverse reaction, and the level of cellular immune response can be equivalent to that of intramuscular injection. Moreover, intramuscular injection can produce more high-level neutralizing antibodies, so we can clearly know that the effect of this vaccine is very good.

To sum up, we can clearly know that after the inhalation mode of this vaccine is changed to atomization, the local muscle reaction is reduced less, and its efficacy in preventing COVID-19 is almost the same as that of the original traditional vaccine, but it can better provide corresponding safety.